SCP2-specific inhibitors are known to induce autophagy in tumor cells by inhibiting the AKT1-mTOR signaling pathway, thereby suppressing tumor cell proliferation (Liu et al., 2014). This evidence concerns the gene AKT1 and neoplasm.